SCHEMBL30937659

SCHEMBL30937659

CC(C)(C)OC(=O)CN1Cc2c(C#N)cncc2NC1=O

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GPR119 Q8TDV5 5/20 0.36
▸ RIPK1 Q13546 8/20 0.35
▸ PLA2G10 O15496 1/20 0.35
▸ PLA2G5 P39877 1/20 0.35
▸ GLA P06280 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ACE P12821 1/20 0.32
▸ MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937643 0.85 MMP13 (0.41) ALDH1A1KDM4EKMT2APLA2G10PLA2G5
SCHEMBL30937590 0.84 SCN9A (0.38) ALDH1A1KDM4EGPR119RIPK1PLA2G10
SCHEMBL30937550 0.83 ACE (0.45) ALDH1A1KDM4EMEN1MAPTRAB9A
SCHEMBL30937570 0.82 ACE (0.36) RIPK1ACEMMP13
SCHEMBL30937741 0.79 ACE (0.36) ALDH1A1KDM4EMEN1MAPTRAB9A
SCHEMBL30937599 0.73 DRD2 (0.39) ALDH1A1KDM4EMEN1MAPTRAB9A
SCHEMBL30937608 0.72 ACE (0.42) ALDH1A1KDM4EPLA2G10PLA2G5MAPK1
SCHEMBL30937730 0.71 ACE (0.49) ALDH1A1KDM4EMEN1RAB9AKMT2A
SCHEMBL30937656 0.71 ACE (0.37) ALDH1A1KDM4EPLA2G10PLA2G5MAPK1
SCHEMBL30937552 0.68 PLA2G10 (0.38) PLA2G10PLA2G5MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback